Home - Products - MAPK/ERK Signaling - JNK - Caffeic Acid

Caffeic Acid

CAS No. 331-39-5

Caffeic Acid( —— )

Catalog No. M18430 CAS No. 331-39-5

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	28	In Stock
100MG	27	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Caffeic Acid
Note

Research use only, not for human use.
Brief Description

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
Description

Caffeic Acid is an orally bioavailable, hydroxycinnamic acid derivative and polyphenol, with potential anti-oxidant, anti-inflammatory, and antineoplastic activities.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

JNK
Recptor

Others
Research Area

Others-Field
Indication

——

Chemical Information

CAS Number

331-39-5
Formula Weight

180.16
Molecular Formula

C9H8O4
Purity

>98% (HPLC)
Solubility

DMSO : 106.7 mg/mL 592.25 mM
SMILES

c1cc(c(cc1/C=C/C(=O)O)O)O
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. Pradhananga S, Shim WS. Eur J Pharmacol. 2015 Sep 5;762:313-21.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

J30-8

J30-8 is a subtype-selective and potent JNK3 inhibitor (IC50: 40 nM) with neuroprotective activity for the study of neurodegenerative diseases such as Alzheimer's disease.
d-Epigalbacin

d-Epigalbacin is a naturally occurring lignin. d-Epigalbacin is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively.
GSK2879552 2HCl

GSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), with potential antineoplastic activity.

Sign In Join Free